Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated whether the assembly/disassembly of the 26S
proteasome
is regulated by phosphorylation/dephosphorylation. The regulatory complex disassembled from the 26S
proteasome
was capable of phosphorylating the p45/Sug1/Rpt6 subunit, suggesting that the protein kinase is activated upon dissociation of the 26S
proteasome
or that the phosphorylation site of p45 becomes susceptible to the protein kinase. In addition, the p45-phosphorylated regulatory complex was found to be incorporated into the 26S
proteasome
. When the 26S
proteasome
was treated with alkaline phosphatase, it was dissociated into the 20S
proteasome
and the regulatory complex. Furthermore, the p45 subunit and the C3/alpha2 subunit were cross-linked with
DTBP
, whereas these subunits were not cross-linked by dephosphorylating the 26S
proteasome
. These results indicate that the 26S
proteasome
is disassembled into the constituent subcomplexes by dephosphorylation and that it is assembled by phosphorylation of p45 by a protein kinase, which is tightly associated with the regulatory complex. It was also revealed that the p45 subunit is directly associated with the 20S
proteasome
alpha-subunit C3 in a phosphorylation-dependent manner.
...
PMID:Assembly of the 26S proteasome is regulated by phosphorylation of the p45/Rpt6 ATPase subunit. 1114 24